Final ID:
Hanna Mazen, Sailer Christine, Kittleson Michelle
Do Emerging HFpEF Treatments Work? The Role of Non-disease Modifying Treatments including SGLT2i, MRAs, GLP1s, and implantable hemodynamic monitors in Cardiac Amyloidosis.Cuddy Sarah, Griffin Jan